Sex, race, and BMI in clinical trials of medications for obesity over the past three decades: a systematic review
Year: 2024
Type: review
Study design: Systematic Review
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: anti-obesity drugs, body mass index, sex differences, racial diversity, underrepresented groups, trial recruitment, demographic representation, type 2 diabetes, orlistat, naltrexone/bupropion, liraglutide, semaglutide, lorcaserin, sibutramine, rimonabant, tirzepatide, retatrutide, orforglipron
Open Access status: closed
Funder: University College Dublin
OpenAlex ID: W4396675284
